Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2023

Jul 11, 2023

34412_dirs_2023-07-11_5e12c91b-0041-4ee5-a338-eca4c215d312.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2023-07-10

Reporting Person: Peng Katie (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-07-10 Stock Option (Right to Buy) $3.38 A 70200 Acquired 2033-07-09 Common Stock (70200) Direct

Footnotes

F1: These shares shall vest in thirty-six (36) equal monthly installments beginning July 10, 2023.